Beijing Youan Hospital
Beijing Youan Hospital: China's National Stronghold in Infectious Disease and Liver Disease Prevention
Affiliated with Capital Medical University, Beijing Youan Hospital is a Grade A tertiary infectious disease specialty hospital directly under the Beijing Municipal Health Commission. It serves as the base institution for the National Clinical Research Center for Infectious Diseases and the Beijing Institute of Hepatology, standing as a national “technical benchmark” and “emergency vanguard” in infectious disease prevention and control. Founded in 1956 as the “Beijing First Infectious Disease Hospital,” the institution has evolved over nearly seven decades into a national medical center integrating medical care, teaching, research, and prevention. With core expertise in infectious diseases, liver disorders, and HIV/AIDS, it serves patients from all 31 provinces (autonomous regions and municipalities) across China and over 100 countries worldwide. Annual outpatient visits exceed 1.8 million, and it performs over 12,000 surgeries annually. Its diagnostic and therapeutic technologies in complex infectious diseases, end-stage liver disease, and HIV/AIDS treatment are internationally leading.
I. Hospital Profile: The National Team Guarding the “Frontline of Life” in Infectious Disease Control
Located at No. 8, Xitiao Road, Yuanguomenwai, Fengtai District, Beijing, adjacent to the Yuanguomen commercial district, the hospital spans a total floor area of approximately 310,000 square meters. It operates over 1,900 beds and employs more than 3,000 staff members, including over 500 senior-level specialists and more than 150 doctoral/master's supervisors. The hospital organizes its operations around four core disciplinary clusters: “Infectious Diseases,” “Hepatology,” HIV/AIDS,“ and ”Hepatobiliary Surgery," along with supporting departments such as Critical Care Medicine, Interventional Therapy, and Pathology. It houses key national and provincial/ministerial platforms, including the National Clinical Research Center for Infectious Diseases, Beijing Artificial Liver Treatment and Training Center, and the Key Laboratory of Infectious Diseases under the National Administration of Traditional Chinese Medicine. As a doctoral/master's training base for Capital Medical University in Infectious Diseases, Hepatology, and Clinical Laboratory Diagnostics, it cultivates hundreds of infectious disease specialists annually for the nation. During the 2020 COVID-19 pandemic, as a designated treatment hospital in Beijing, the institution achieved the remarkable feat of “zero infections and zero deaths,” demonstrating its commitment to public health emergency response.
II. Technical Advantages: Full-chain Breakthroughs from “Hepatitis Expert” to “HIV Expert”
Guided by the mission to “solve complex challenges and drive innovation,” the hospital has established a comprehensive “prevention-diagnosis-treatment-rehabilitation” technical system across infectious diseases, hepatology, and HIV/AIDS:
• Hepatitis and Cirrhosis: “Functional Cure” Rewrites Prognosis
For chronic hepatitis B and C, the hospital pioneered treatments including “nucleoside analogues + interferon combination therapy” and “genotype-specific direct-acting antiviral (DAA) regimens for HCV.” Clinical cure rates for hepatitis B reached 35% (exceeding the international average), while HCV cure rates surpassed 98%. For cirrhosis treatment, innovative procedures like “Transjugular Intrahepatic Portosystemic Shunt (TIPS)” and “Endoscopic Precision Ligation of Esophageal and Gastric Varices” have reduced mortality from variceal bleeding in cirrhotic patients from 30% to below 5%.
• Hepatocellular Carcinoma: “Multimodal Therapy” Extends Survival
Hepatobiliary Surgery performs high-complexity procedures, including “Da Vinci Robot-Assisted Hepatectomy” and “ALPPS (Two-Stage Hepatectomy with Combined Liver Disconnection and Portal Vein Ligation)”, achieving a 5-year survival rate of 65% (leading nationally). The Oncology Department implements a combined “targeted therapy + immunotherapy + local ablation” regimen, achieving an objective response rate (ORR) of 40% for unresectable hepatocellular carcinoma. The Interventional Radiology Department employs “transarterial chemoembolization (TACE) + drug-eluting microspheres” technology, extending survival beyond 2 years for patients with advanced hepatocellular carcinoma.
• HIV/AIDS: “Comprehensive Management” Enhances Quality of Life
As one of China's earliest institutions to implement standardized HIV treatment, the AIDS Department pioneered a model integrating “precision prevention of opportunistic infections + individualized antiviral therapy + psychological intervention.” Antiviral treatment coverage exceeds 95% among HIV-infected individuals, reducing mortality rates from 15% in 2003 to below 1% today. For AIDS-related opportunistic infections (e.g., Pneumocystis pneumonia, cryptococcal meningitis), the department employs “rapid pathogen diagnosis + novel antifungal drugs” treatment, achieving a rescue success rate exceeding 90%.
• Critical Infections: “Artificial Liver + ECMO” Dual Approach
The Intensive Care Unit (ICU) is equipped with internationally advanced artificial liver support systems (DPMAS + plasma exchange) and ECMO (extracorporeal membrane oxygenation) devices. It has successfully treated numerous patients with severe hepatitis, sepsis, and septic shock. The 28-day survival rate for acute liver failure patients reaches 78% (leading in China).
III. Leading Specialties: A Core Discipline Matrix Covering Prevention, Diagnosis, Treatment, and Rehabilitation
The hospital boasts seven National Key Clinical Specialties (Infectious Diseases, Hepatology Center, HIV/AIDS, Hepatobiliary Surgery, Critical Care Medicine, Radiology, Pathology), including:
• Infectious Diseases Department: One of China's largest infectious disease centers, treating over 50,000 patients annually. It possesses extensive expertise in managing complex cases such as unexplained fever, central nervous system infections, and non-tuberculous mycobacterial diseases. It has ranked first in infectious diseases on Fudan University's “China Hospital Specialty Rankings” for 12 consecutive years.
• Liver Disease Center: Integrates diagnosis and treatment of hepatitis, cirrhosis, and hepatocellular carcinoma. Performs over 10,000 liver biopsy procedures annually, achieving 95% accuracy in non-invasive liver fibrosis diagnosis (FibroScan) and a 40% success rate in cirrhosis reversal therapy (world-leading).
• AIDS Department: As the National AIDS Diagnosis and Treatment Quality Control Center, it spearheaded the development of the Chinese AIDS Diagnosis and Treatment Guidelines. Its post-exposure prophylaxis (PEP) success rate exceeds 99%, making it one of the world's largest AIDS clinical research bases.
• Hepatobiliary Surgery: A National Key Specialty excelling in complex hepatocellular carcinoma (e.g., involving major vessels, multiple metastases) and end-stage liver disease liver transplantation. Annual liver transplant volume exceeds 300 cases with a 1-year survival rate of 92% (among the highest nationally).
IV. Departmental Structure: Comprehensive Patient Care
Beyond core specialties, the hospital houses:
• Infectious Disease Center (treating brucellosis, dengue fever, etc.)
• Gastroenterology (managing cirrhosis complications)
• Obstetrics and Gynecology (hepatitis B/HIV mother-to-child transmission prevention)
• Dermatology and Venereology (standardized treatment for genital warts, syphilis), Laboratory Center (viral load and drug resistance testing), Radiology Department (hepatic arteriography, dynamic contrast-enhanced liver MRI), and over 30 other clinical departments. Supported by ancillary departments like Pathology (liver histological grading, molecular tumor pathology) and Ultrasound (hepatocellular tumor contrast-enhanced ultrasound), the hospital forms an integrated “diagnosis-treatment-rehabilitation” service network.
V. Medical Equipment: World-Class Technology Enabling Precision Diagnosis and Treatment
The hospital is equipped with globally leading medical devices to support the diagnosis and treatment of complex and critical conditions:
• Viral and Genetic Testing Equipment:
• Roche Cobas 6800 Fully Automated Nucleic Acid Analyzer (gold standard for HBV/HCV viral load testing)
• Illumina NextSeq 550 Sequencer (HIV drug resistance gene and HCC driver gene detection)
• Hepatology Treatment Systems: Fresenius (Germany) Artificial Liver Support System (DPMAS + Plasma Exchange), Olympus (Japan) Electronic Gastroscope (Precision Treatment for Esophageal/Gastric Varices), Echosens (France) FibroScan 502 (Non-invasive Liver Fibrosis Diagnosis).
• Oncology and Surgical Equipment: Siemens PET-CT (Germany) (early liver cancer screening), Philips Ingenia 3.0T MRI (Netherlands) (precision imaging of liver tumors), Da Vinci Xi Surgical Robot (minimally invasive procedures including liver resection and kidney transplantation).
• Critical Care and Emergency Equipment: • Medtronic (USA) ECMO (extracorporeal membrane oxygenation) • Dräger (Germany) Evita V300 ventilator (ARDS treatment) • Terumo (Japan) Continuous Renal Replacement Therapy (CRRT) system.
VI. International Patient Services: China's Solution for Global Healthcare
As a “World Health Organization (WHO) Collaborating Center” and a “Designated Foreign Medical Service Provider by the National Health Commission,” the hospital serves as a key referral destination for infectious disease, liver disease, and HIV/AIDS patients from Southeast Asia, Africa, Europe, and the Americas. It offers comprehensive, streamlined services for international patients:
• Multilingual Support: Our International Medical Department employs professional translators fluent in English, French, Spanish, Swahili, and other languages. Medical staff can communicate in basic foreign languages. Critical examination reports (e.g., CT scans, pathology) are provided in both Chinese and English.
• One-Stop Service: We assist international patients with registration, examination scheduling, medical record translation, visa extensions, and other procedures. Priority access is offered for appointments (emergency patients seen within 30 minutes).
• International Insurance Coverage: Collaborates with global insurers, including MSH (Wanxinhe), Cigna, and Aetn, to facilitate direct billing for overseas medical insurance; accepts international credit cards and cross-border payments (Alipay/WeChat Pay).
• Cultural Adaptation Services: Provide diverse dietary options, including halal meals, vegetarian options, and low-fat meals in patient rooms; respect religious customs (e.g., Islamic prayer times, Christian holiday greetings); equipped with religious activity rooms and dedicated psychological counseling specialists.
• Telemedicine: Collaborations established with Johns Hopkins Hospital (USA), Royal Free Hospital (UK), and University of the Witwatersrand Hospital (South Africa) enable video-linked international expert consultations for complex cases.
VII. International Patient Testimonials: “Technical Excellence, Humanistic Care”
• Thabo (38, hepatitis B-related cirrhosis, South Africa): “After trying multiple treatments in South Africa with worsening liver function, You'an Hospital's doctors developed a combined ‘antiviral + anti-fibrotic + artificial liver’ regimen. Within three months, my liver function markers significantly improved. Nurses taught me daily to track diet and symptoms via a mobile app, and upon discharge, they provided me with the English edition of the Hepatitis B Self-Management Handbook.” "
• American patient Luna (29, HIV with Pneumocystis pneumonia): “I never thought I'd live past 30. But in Youan's ICU, doctors treated me with ECMO and novel antifungal drugs for 14 days—I miraculously pulled through! Now my CD4 count has risen from 200 to 500. Doctors say I can live like a healthy person.” "
• Myanmar patient Ko Min Lwin (45, advanced liver cancer): “The hepatobiliary surgeons used the Da Vinci robot to remove my right hepatic lobe. The surgical incision was only 5cm, and I was able to get out of bed within a week post-op. The oncology team designed an immunotherapy-targeted combination regimen for me. Now my tumor has shrunk by 40%—I truly see hope!”
VIII. Contact Information & Transportation Guide
• Hospital Address: No. 8, Xitiao Road, Yuangmenwai, Fengtai District, Beijing (Main Campus of Beijing Youan Hospital Affiliated to Capital Medical University).
• Consultation Hotline: 010-83997500 (Main Switchboard), 010-83997120 (International Patient Service Line).
• WeChat Official Account: Search “Beijing Youan Hospital Service Account” for online appointments, report inquiries, and access infection/liver disease prevention resources.
• Transportation Routes:
• Subway: Exit A at Youanmenwai Station (Line 19), 5-minute walk;
• Bus: Take routes 19, 48, 72, etc., and alight at “Youanmenwai Station”;
• Driving: The hospital features an underground parking garage (rate: ¥8/hour). Nearby parking is available at the public lot under Youanmen Bridge (10-minute walk).
Beijing Youan Hospital upholds the mission of “Life First, Health Guardian.” With its deep expertise in infectious diseases, hepatology, and HIV/AIDS, continuous technological innovation, and compassionate care for patients worldwide, it remains a trusted “Guardian of Infectious Disease and Liver Health.” Whether providing standardized treatment for common hepatitis or tackling complex critical cases through multidisciplinary collaboration, the hospital delivers high-quality, compassionate medical services to patients worldwide, embodying “Chinese wisdom.”
Document dated 2025-09-15 14:47 Modify